COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Low Fat Diet for Fatigue in MS

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03322982
Recruitment Status : Recruiting
First Posted : October 26, 2017
Last Update Posted : April 13, 2020
Sponsor:
Collaborator:
National Multiple Sclerosis Society
Information provided by (Responsible Party):
Vijayshree Yadav, Oregon Health and Science University

Brief Summary:
A randomized, controlled pilot trial of a dietary intervention vs. wait-list control in patients with MS and fatigue for management of their fatigue. The hypothesis of this study is that participants following the low-fat study diet will demonstrate a significant reduction in fatigue after four months compared to wait list controls.

Condition or disease Intervention/treatment Phase
Multiple Sclerosis Behavioral: Low-fat diet Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 108 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Masking Description: Diet adherence assessments will be conducted by blinded assessors from OHSU bionutrition team.
Primary Purpose: Other
Official Title: A Randomized, Controlled Trial of Low-fat Diet for Fatigue in Multiple Sclerosis
Actual Study Start Date : August 15, 2018
Estimated Primary Completion Date : September 30, 2020
Estimated Study Completion Date : March 31, 2021

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: MS Diet
34 people with MS following low-fat diet
Behavioral: Low-fat diet
less than 20% calories from fat daily

No Intervention: MS Wait-List
34 people with MS following usual diet
No Intervention: Diet Healthy Control
20 controls with no diagnosis of MS, age and sex-matched to members of the MS Diet group
No Intervention: Wait-List Healthy Control
20 controls with no diagnosis of MS, age and sex-matched to members of the MS Wait-List group



Primary Outcome Measures :
  1. Fatigue [ Time Frame: Baseline to month 4 ]
    Measured by Modified Fatigue Impact Scale (MFIS). The MFIS is a 21-item questionnaire that assesses overall self-reported fatigue. Subjects rate agreement with a series of statements on a scale of 0 (rarely) to 4 (almost always), in context of their fatigue over the preceding four weeks. Total possible score of 84. Individuals with an MFIS score of > 38 are considered to experience moderate to severe "fatigue


Secondary Outcome Measures :
  1. Fatigue [ Time Frame: Baseline to month 4 ]
    Measured by Fatigue Severity Scale (FSS). The FSS is a 9-item questionnaire, with subjects giving a response from 1-7 to indicate their degree of agreement with each statement.

  2. Disability [ Time Frame: Baseline to month 4 ]
    Measured by EDSS. The EDSS is an eight functional system scale including motor, sensory, cerebellar, brain stem, visual, mental, sphincteric, and other systems. Each functional system is graded from 0 (no disability) to 5 or 6 (maximal disability)20. An integrated score between 0 (normal examination) and 10 (death from MS) is formed based on the score in each functional system.


Other Outcome Measures:
  1. Microbiome- Relative abundance of targeted species of gut microflora [ Time Frame: Baseline to month 4 ]
    Measured by 16S rRNA sequencing



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 70 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

For participants with MS:

Inclusion Criteria:

  • Age 18-70
  • Diagnosis of MS by 2010 McDonald Criteria
  • EDSS ≤ 7.5
  • Experiencing moderate to severe fatigue (MFIS ≥ 38)

Exclusion Criteria:

  • Current cardiopulmonary disease requiring treatment
  • Diabetes
  • Pregnancy or breast-feeding
  • MS exacerbation within 30 days of screening visit
  • IV steroids within 30 days of screening visit
  • Dietary fat content of <30% as assessed by food frequency questionnaire (FFQ) at screening visit
  • Fish oil or flax seed oil supplementation within 30 days of screening visit

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03322982


Contacts
Layout table for location contacts
Contact: Anna Orban 503-494-3549 orban@ohsu.edu

Locations
Layout table for location information
United States, Oregon
Oregon Health Science University Recruiting
Portland, Oregon, United States, 97239
Contact: Vijayshree Yadav         
Sponsors and Collaborators
Oregon Health and Science University
National Multiple Sclerosis Society
Investigators
Layout table for investigator information
Principal Investigator: Vijayshree Yadav Oregon Health and Science University
Layout table for additonal information
Responsible Party: Vijayshree Yadav, Associate Professor of Neurology, Oregon Health and Science University
ClinicalTrials.gov Identifier: NCT03322982    
Other Study ID Numbers: OHSU IRB16600
First Posted: October 26, 2017    Key Record Dates
Last Update Posted: April 13, 2020
Last Verified: April 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Vijayshree Yadav, Oregon Health and Science University:
diet, low-fat
Additional relevant MeSH terms:
Layout table for MeSH terms
Multiple Sclerosis
Sclerosis
Fatigue
Pathologic Processes
Demyelinating Autoimmune Diseases, CNS
Autoimmune Diseases of the Nervous System
Nervous System Diseases
Demyelinating Diseases
Autoimmune Diseases
Immune System Diseases